{"date":"2026-02-26","count":83,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-4153-2026-02-26-2139-11wjw0o","company_id":"4153","company":"鈺緯","market":"上櫃","industry":"生技醫療","date":"2026-02-26","time":"21:39:23","subject":"公告本公司董事會決議股利分派","clause":"第14款","fact_date":"2026-02-26","cite_as":"公開資訊觀測站重大訊息：鈺緯（4153），2026-02-26 21:39，「公告本公司董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4153-2026-02-26-2138-1dd9qx8","company_id":"4153","company":"鈺緯","market":"上櫃","industry":"生技醫療","date":"2026-02-26","time":"21:38:43","subject":"公告本公司董事會決議召開115年股東常會事宜","clause":"第17款","fact_date":"2026-02-26","cite_as":"公開資訊觀測站重大訊息：鈺緯（4153），2026-02-26 21:38，「公告本公司董事會決議召開115年股東常會事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4153-2026-02-26-2137-5j9yh6","company_id":"4153","company":"鈺緯","market":"上櫃","industry":"生技醫療","date":"2026-02-26","time":"21:37:31","subject":"公告本公司董事會通過114年度合併財務報告","clause":"第31款","fact_date":"2026-02-26","cite_as":"公開資訊觀測站重大訊息：鈺緯（4153），2026-02-26 21:37，「公告本公司董事會通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6662-2026-02-26-2058-ihr60n","company_id":"6662","company":"樂斯科","market":"上櫃","industry":"生技醫療","date":"2026-02-26","time":"20:58:18","subject":"公告本公司114年度自結財務資訊董事會召開日期為115年3月6日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：樂斯科（6662），2026-02-26 20:58，「公告本公司114年度自結財務資訊董事會召開日期為115年3月6日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4744-2026-02-26-1944-iqa9gy","company_id":"4744","company":"皇將","market":"上櫃","industry":"生技醫療","date":"2026-02-26","time":"19:44:23","subject":"對造人楊建夫依據114年12月2日重訊公告之一審判決書向法院聲請部分假執行","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：皇將（4744），2026-02-26 19:44，「對造人楊建夫依據114年12月2日重訊公告之一審判決書向法院聲請部分假執行」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6861-2026-02-26-1924-ghwvcs","company_id":"6861","company":"睿生光電","market":"上市","industry":"生技醫療","date":"2026-02-26","time":"19:24:46","subject":"代重要子公司Innocare Optoelectronics USA,Inc.公告董事異動暨董事變動達三分之一以上","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：睿生光電（6861），2026-02-26 19:24，「代重要子公司Innocare Optoelectronics USA,Inc.公告董事異動暨董事變動達三分之一以上」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6861-2026-02-26-1924-az4rjf","company_id":"6861","company":"睿生光電","market":"上市","industry":"生技醫療","date":"2026-02-26","time":"19:24:10","subject":"代重要子公司Innocare Optoelectronics USA,Inc.公告董事長暨總經理異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：睿生光電（6861），2026-02-26 19:24，「代重要子公司Innocare Optoelectronics USA,Inc.公告董事長暨總經理異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7851-2026-02-26-1914-1isegwk","company_id":"7851","company":"慧康生技*-KY","market":"興櫃","industry":"生技醫療","date":"2026-02-26","time":"19:14:38","subject":"代重要子公司SYNCHEALTH LTD.公告董事會決議辦理現金增資","clause":"第9款","fact_date":"2026-02-26","cite_as":"公開資訊觀測站重大訊息：慧康生技*-KY（7851），2026-02-26 19:14，「代重要子公司SYNCHEALTH LTD.公告董事會決議辦理現金增資」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7851-2026-02-26-1901-1wpjftt","company_id":"7851","company":"慧康生技*-KY","market":"興櫃","industry":"生技醫療","date":"2026-02-26","time":"19:01:27","subject":"公告本公司董事會決議通過現金增資子公司慧康數位醫療器材有限公司","clause":"第17款","fact_date":"2026-02-26","cite_as":"公開資訊觀測站重大訊息：慧康生技*-KY（7851），2026-02-26 19:01，「公告本公司董事會決議通過現金增資子公司慧康數位醫療器材有限公司」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7851-2026-02-26-1900-169sj3v","company_id":"7851","company":"慧康生技*-KY","market":"興櫃","industry":"生技醫療","date":"2026-02-26","time":"19:00:51","subject":"公告本公司董事會決議通過現金增資子公司SYNCHEALTH LTD.","clause":"第17款","fact_date":"2026-02-26","cite_as":"公開資訊觀測站重大訊息：慧康生技*-KY（7851），2026-02-26 19:00，「公告本公司董事會決議通過現金增資子公司SYNCHEALTH LTD.」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7851-2026-02-26-1856-1howjn","company_id":"7851","company":"慧康生技*-KY","market":"興櫃","industry":"生技醫療","date":"2026-02-26","time":"18:56:51","subject":"公告本公司董事會決議召開115年股東常會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：慧康生技*-KY（7851），2026-02-26 18:56，「公告本公司董事會決議召開115年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6469-2026-02-26-1817-1howjn","company_id":"6469","company":"大樹","market":"上櫃","industry":"生技醫療","date":"2026-02-26","time":"18:17:05","subject":"公告本公司董事會決議召開115年股東常會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：大樹（6469），2026-02-26 18:17，「公告本公司董事會決議召開115年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6469-2026-02-26-1815-uydxma","company_id":"6469","company":"大樹","market":"上櫃","industry":"生技醫療","date":"2026-02-26","time":"18:15:40","subject":"本公司董事會決議辦理私募國內無擔保可轉換公司債","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：大樹（6469），2026-02-26 18:15，「本公司董事會決議辦理私募國內無擔保可轉換公司債」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6469-2026-02-26-1815-1mt3uer","company_id":"6469","company":"大樹","market":"上櫃","industry":"生技醫療","date":"2026-02-26","time":"18:15:15","subject":"本公司董事會決議辦理私募普通股","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：大樹（6469），2026-02-26 18:15，「本公司董事會決議辦理私募普通股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6469-2026-02-26-1814-15mqprv","company_id":"6469","company":"大樹","market":"上櫃","industry":"生技醫療","date":"2026-02-26","time":"18:14:52","subject":"本公司經董事會決議發行一一五年度員工認股權憑證","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：大樹（6469），2026-02-26 18:14，「本公司經董事會決議發行一一五年度員工認股權憑證」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6469-2026-02-26-1814-b31x","company_id":"6469","company":"大樹","market":"上櫃","industry":"生技醫療","date":"2026-02-26","time":"18:14:20","subject":"公告本公司董事會通過盈餘轉增資發行新股案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：大樹（6469），2026-02-26 18:14，「公告本公司董事會通過盈餘轉增資發行新股案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6469-2026-02-26-1813-11wjw0o","company_id":"6469","company":"大樹","market":"上櫃","industry":"生技醫療","date":"2026-02-26","time":"18:13:47","subject":"公告本公司董事會決議股利分派","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：大樹（6469），2026-02-26 18:13，「公告本公司董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6469-2026-02-26-1812-e6hr0k","company_id":"6469","company":"大樹","market":"上櫃","industry":"生技醫療","date":"2026-02-26","time":"18:12:16","subject":"公告本公司董事會通過114年度合併財務報表","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：大樹（6469），2026-02-26 18:12，「公告本公司董事會通過114年度合併財務報表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6657-2026-02-26-1812-5j9yh6","company_id":"6657","company":"華安","market":"上市","industry":"生技醫療","date":"2026-02-26","time":"18:12:11","subject":"公告本公司董事會通過114年度合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：華安（6657），2026-02-26 18:12，「公告本公司董事會通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6469-2026-02-26-1811-nwho7y","company_id":"6469","company":"大樹","market":"上櫃","industry":"生技醫療","date":"2026-02-26","time":"18:11:38","subject":"公告本公司董事會通過114年度董事酬勞及員工酬勞分派","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：大樹（6469），2026-02-26 18:11，「公告本公司董事會通過114年度董事酬勞及員工酬勞分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6657-2026-02-26-1807-11b1948","company_id":"6657","company":"華安","market":"上市","industry":"生技醫療","date":"2026-02-26","time":"18:07:00","subject":"公告本公司董事會決議召開115年股東常會相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：華安（6657），2026-02-26 18:07，「公告本公司董事會決議召開115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6703-2026-02-26-1806-73vksw","company_id":"6703","company":"軒郁","market":"上櫃","industry":"生技醫療","date":"2026-02-26","time":"18:06:58","subject":"公告本公司114年第四季合併財務報告董事會預計召開日期為115年3月6日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：軒郁（6703），2026-02-26 18:06，「公告本公司114年第四季合併財務報告董事會預計召開日期為115年3月6日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6657-2026-02-26-1805-bwopfv","company_id":"6657","company":"華安","market":"上市","industry":"生技醫療","date":"2026-02-26","time":"18:05:30","subject":"公告本公司董事會決議不分派股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：華安（6657），2026-02-26 18:05，「公告本公司董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7713-2026-02-26-1801-1gndp03","company_id":"7713","company":"威力德生醫","market":"上櫃","industry":"生技醫療","date":"2026-02-26","time":"18:01:45","subject":"公告本公司出租辦公室予關係人(提前終止租約)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：威力德生醫（7713），2026-02-26 18:01，「公告本公司出租辦公室予關係人(提前終止租約)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6499-2026-02-26-1801-11b1948","company_id":"6499","company":"益安","market":"上櫃","industry":"生技醫療","date":"2026-02-26","time":"18:01:41","subject":"公告本公司董事會決議召開115年股東常會相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：益安（6499），2026-02-26 18:01，「公告本公司董事會決議召開115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7713-2026-02-26-1801-164qu0a","company_id":"7713","company":"威力德生醫","market":"上櫃","industry":"生技醫療","date":"2026-02-26","time":"18:01:03","subject":"公告本公司處分(轉租)使用權資產予子公司優品生醫股份有限公司(提前終止租約)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：威力德生醫（7713），2026-02-26 18:01，「公告本公司處分(轉租)使用權資產予子公司優品生醫股份有限公司(提前終止租約)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6973-2026-02-26-1757-mph3st","company_id":"6973","company":"永立榮","market":"興櫃","industry":"生技醫療","date":"2026-02-26","time":"17:57:43","subject":"公告本公司變更限制員工權利新股增資基準日","clause":"第44款","fact_date":"2026-02-26","cite_as":"公開資訊觀測站重大訊息：永立榮（6973），2026-02-26 17:57，「公告本公司變更限制員工權利新股增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7713-2026-02-26-1753-18lc6w6","company_id":"7713","company":"威力德生醫","market":"上櫃","industry":"生技醫療","date":"2026-02-26","time":"17:53:28","subject":"代重要子公司優品生醫股份有限公司公告向本公司取得使用權資產","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：威力德生醫（7713），2026-02-26 17:53，「代重要子公司優品生醫股份有限公司公告向本公司取得使用權資產」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6734-2026-02-26-1749-256eua","company_id":"6734","company":"安盛生","market":"興櫃","industry":"生技醫療","date":"2026-02-26","time":"17:49:34","subject":"公告本公司115年1月份自結財務報告之負債比率、流動比率、速動比率、預估未來三個月現金收支情形及銀行可使用融資額度情形","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安盛生（6734），2026-02-26 17:49，「公告本公司115年1月份自結財務報告之負債比率、流動比率、速動比率、預估未來三個月現金收支情形及銀行可使用融資額度情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1786-2026-02-26-1746-1094bzp","company_id":"1786","company":"科妍","market":"上市","industry":"生技醫療","date":"2026-02-26","time":"17:46:10","subject":"公告本公司114年第四季財務報告董事會預計召開日期為115年03月06日","clause":"第31款","fact_date":"2026-02-26","cite_as":"公開資訊觀測站重大訊息：科妍（1786），2026-02-26 17:46，「公告本公司114年第四季財務報告董事會預計召開日期為115年03月06日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6499-2026-02-26-1741-1mvy42n","company_id":"6499","company":"益安","market":"上櫃","industry":"生技醫療","date":"2026-02-26","time":"17:41:11","subject":"公告本公司董事會決議股利分派情形","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：益安（6499），2026-02-26 17:41，「公告本公司董事會決議股利分派情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7713-2026-02-26-1734-11b1948","company_id":"7713","company":"威力德生醫","market":"上櫃","industry":"生技醫療","date":"2026-02-26","time":"17:34:31","subject":"公告本公司董事會決議召開115年股東常會相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：威力德生醫（7713），2026-02-26 17:34，「公告本公司董事會決議召開115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4157-2026-02-26-1733-vmr9nv","company_id":"4157","company":"太景*-KY","market":"上櫃","industry":"生技醫療","date":"2026-02-26","time":"17:33:43","subject":"公告114年第4季財務報告董事會召開日期為115年03月09日","clause":"第31款","fact_date":"2026-02-26","cite_as":"公開資訊觀測站重大訊息：太景*-KY（4157），2026-02-26 17:33，「公告114年第4季財務報告董事會召開日期為115年03月09日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7713-2026-02-26-1733-hcclaf","company_id":"7713","company":"威力德生醫","market":"上櫃","industry":"生技醫療","date":"2026-02-26","time":"17:33:08","subject":"代重要子公司優品生醫股份有限公司公告決議盈餘分配案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：威力德生醫（7713），2026-02-26 17:33，「代重要子公司優品生醫股份有限公司公告決議盈餘分配案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7713-2026-02-26-1732-17xcq16","company_id":"7713","company":"威力德生醫","market":"上櫃","industry":"生技醫療","date":"2026-02-26","time":"17:32:49","subject":"公告本公司訂定114年除息基準日相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：威力德生醫（7713），2026-02-26 17:32，「公告本公司訂定114年除息基準日相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6547-2026-02-26-1730-s9538l","company_id":"6547","company":"高端疫苗","market":"上櫃","industry":"生技醫療","date":"2026-02-26","time":"17:30:56","subject":"公告本公司國內第二次有擔保轉換公司債委託代收及存儲價款行庫","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：高端疫苗（6547），2026-02-26 17:30，「公告本公司國內第二次有擔保轉換公司債委託代收及存儲價款行庫」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4173-2026-02-26-1729-fixn9z","company_id":"4173","company":"久裕","market":"上櫃","industry":"生技醫療","date":"2026-02-26","time":"17:29:41","subject":"公告114年第四季財務報告董事會預計召開日期為115年03月06日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：久裕（4173），2026-02-26 17:29，「公告114年第四季財務報告董事會預計召開日期為115年03月06日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6499-2026-02-26-1726-1h4hurr","company_id":"6499","company":"益安","market":"上櫃","industry":"生技醫療","date":"2026-02-26","time":"17:26:00","subject":"公告本公司董事會決議辦理私募現金增資發行普通股","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：益安（6499），2026-02-26 17:26，「公告本公司董事會決議辦理私募現金增資發行普通股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4116-2026-02-26-1718-xknpzd","company_id":"4116","company":"明基醫","market":"上櫃","industry":"生技醫療","date":"2026-02-26","time":"17:18:00","subject":"代重要子公司凱圖國際股份有限公司董事會決議分配現金股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：明基醫（4116），2026-02-26 17:18，「代重要子公司凱圖國際股份有限公司董事會決議分配現金股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4114-2026-02-26-1714-8nxorf","company_id":"4114","company":"健喬","market":"上櫃","industry":"生技醫療","date":"2026-02-26","time":"17:14:48","subject":"公告本公司第14次庫藏股買回執行情形","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：健喬（4114），2026-02-26 17:14，「公告本公司第14次庫藏股買回執行情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6499-2026-02-26-1711-1fg50zj","company_id":"6499","company":"益安","market":"上櫃","industry":"生技醫療","date":"2026-02-26","time":"17:11:50","subject":"公告本公司114年度合併財務報告經董事會決議通過","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：益安（6499），2026-02-26 17:11，「公告本公司114年度合併財務報告經董事會決議通過」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6762-2026-02-26-1711-bf2jve","company_id":"6762","company":"達亞","market":"上櫃","industry":"生技醫療","date":"2026-02-26","time":"17:11:20","subject":"114年度財務報告董事會預計召開日期為115年03月09日","clause":"第31款","fact_date":"2026-02-26","cite_as":"公開資訊觀測站重大訊息：達亞（6762），2026-02-26 17:11，「114年度財務報告董事會預計召開日期為115年03月09日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6586-2026-02-26-1706-1stb1zm","company_id":"6586","company":"醣基","market":"興櫃","industry":"生技醫療","date":"2026-02-26","time":"17:06:35","subject":"本公司醣抗原抗體抗癌新藥(簡稱:CHO-A04)臨床試驗申請案，接獲台灣衛福部食品藥物管理署(TFDA)同意進行一期人體臨床試驗","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：醣基（6586），2026-02-26 17:06，「本公司醣抗原抗體抗癌新藥(簡稱:CHO-A04)臨床試驗申請案，接獲台灣衛福部食品藥物管理署(TFDA)同意進行一期人體」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4105-2026-02-26-1706-vq23wq","company_id":"4105","company":"東洋","market":"上櫃","industry":"生技醫療","date":"2026-02-26","time":"17:06:16","subject":"公告本公司114年第四季財務報告董事會預計召開日期為115年03月09日","clause":"第31款","fact_date":"2026-02-26","cite_as":"公開資訊觀測站重大訊息：東洋（4105），2026-02-26 17:06，「公告本公司114年第四季財務報告董事會預計召開日期為115年03月09日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4116-2026-02-26-1703-10t69z4","company_id":"4116","company":"明基醫","market":"上櫃","industry":"生技醫療","date":"2026-02-26","time":"17:03:36","subject":"代重要子公司凱圖國際股份有限公司公告董事會決議召開115年度股東常會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：明基醫（4116），2026-02-26 17:03，「代重要子公司凱圖國際股份有限公司公告董事會決議召開115年度股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4104-2026-02-26-1701-6rtz4v","company_id":"4104","company":"佳醫","market":"上市","industry":"生技醫療","date":"2026-02-26","time":"17:01:07","subject":"公告本公司114年度財務報告董事會預計召開日期為115年3月6日","clause":"第31款","fact_date":"2026-02-26","cite_as":"公開資訊觀測站重大訊息：佳醫（4104），2026-02-26 17:01，「公告本公司114年度財務報告董事會預計召開日期為115年3月6日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7713-2026-02-26-1650-11wjw0o","company_id":"7713","company":"威力德生醫","market":"上櫃","industry":"生技醫療","date":"2026-02-26","time":"16:50:41","subject":"公告本公司董事會決議股利分派","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：威力德生醫（7713），2026-02-26 16:50，「公告本公司董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7713-2026-02-26-1645-5j9yh6","company_id":"7713","company":"威力德生醫","market":"上櫃","industry":"生技醫療","date":"2026-02-26","time":"16:45:27","subject":"公告本公司董事會通過114年度合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：威力德生醫（7713），2026-02-26 16:45，「公告本公司董事會通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7837-2026-02-26-1643-5rax5d","company_id":"7837","company":"啟新生","market":"興櫃","industry":"生技醫療","date":"2026-02-26","time":"16:43:03","subject":"公告本公司董事會決議員工認股權憑證轉換普通股增資基準日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：啟新生（7837），2026-02-26 16:43，「公告本公司董事會決議員工認股權憑證轉換普通股增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6712-2026-02-26-1642-hrmqwp","company_id":"6712","company":"長聖","market":"上櫃","industry":"生技醫療","date":"2026-02-26","time":"16:42:05","subject":"公告本公司董事會決議資本公積轉增資發行新股","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：長聖（6712），2026-02-26 16:42，「公告本公司董事會決議資本公積轉增資發行新股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6712-2026-02-26-1641-10554si","company_id":"6712","company":"長聖","market":"上櫃","industry":"生技醫療","date":"2026-02-26","time":"16:41:49","subject":"公告本公司董事會決議盈餘及資本公積分配情形","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：長聖（6712），2026-02-26 16:41，「公告本公司董事會決議盈餘及資本公積分配情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6712-2026-02-26-1641-5j9yh6","company_id":"6712","company":"長聖","market":"上櫃","industry":"生技醫療","date":"2026-02-26","time":"16:41:21","subject":"公告本公司董事會通過114年度合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：長聖（6712），2026-02-26 16:41，「公告本公司董事會通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6712-2026-02-26-1640-11qiaz3","company_id":"6712","company":"長聖","market":"上櫃","industry":"生技醫療","date":"2026-02-26","time":"16:40:49","subject":"本公司董事會決議召開115年股東常會事宜(新增議案)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：長聖（6712），2026-02-26 16:40，「本公司董事會決議召開115年股東常會事宜(新增議案)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3164-2026-02-26-1632-zcceve","company_id":"3164","company":"景岳","market":"上市","industry":"生技醫療","date":"2026-02-26","time":"16:32:57","subject":"公告114年第四季財務報告董事會召開日期為115年3月9日","clause":"第31款","fact_date":"2026-02-26","cite_as":"公開資訊觀測站重大訊息：景岳（3164），2026-02-26 16:32，「公告114年第四季財務報告董事會召開日期為115年3月9日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4109-2026-02-26-1629-1aew5q2","company_id":"4109","company":"加捷生醫","market":"上櫃","industry":"生技醫療","date":"2026-02-26","time":"16:29:12","subject":"本公司法人董事變更公司名稱","clause":"第6款","fact_date":"2026-02-26","cite_as":"公開資訊觀測站重大訊息：加捷生醫（4109），2026-02-26 16:29，「本公司法人董事變更公司名稱」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6841-2026-02-26-1617-1fjklr8","company_id":"6841","company":"長佳智能","market":"上櫃","industry":"生技醫療","date":"2026-02-26","time":"16:17:40","subject":"公告114年度財務報告董事會預計召開日期為115年3月10日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：長佳智能（6841），2026-02-26 16:17，「公告114年度財務報告董事會預計召開日期為115年3月10日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6876-2026-02-26-1612-1pzjlpi","company_id":"6876","company":"朗齊生醫*","market":"興櫃","industry":"生技醫療","date":"2026-02-26","time":"16:12:30","subject":"公告本公司預估未來三個月現金收支情形及銀行可使用融資額度情形","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：朗齊生醫*（6876），2026-02-26 16:12，「公告本公司預估未來三個月現金收支情形及銀行可使用融資額度情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6637-2026-02-26-1558-1795mw6","company_id":"6637","company":"醫影","market":"上櫃","industry":"生技醫療","date":"2026-02-26","time":"15:58:27","subject":"公告本公司114年度財務報告董事會預計召開日期為115年03月09日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：醫影（6637），2026-02-26 15:58，「公告本公司114年度財務報告董事會預計召開日期為115年03月09日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7878-2026-02-26-1552-hurcou","company_id":"7878","company":"藥祇","market":"興櫃","industry":"生技醫療","date":"2026-02-26","time":"15:52:36","subject":"本公司董事會決議召開115年股東常會相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：藥祇（7878），2026-02-26 15:52，「本公司董事會決議召開115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7725-2026-02-26-1552-11b1948","company_id":"7725","company":"列特博","market":"興櫃","industry":"生技醫療","date":"2026-02-26","time":"15:52:27","subject":"公告本公司董事會決議召開115年股東常會相關事宜","clause":"第32款","fact_date":"2026-02-26","cite_as":"公開資訊觀測站重大訊息：列特博（7725），2026-02-26 15:52，「公告本公司董事會決議召開115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7561-2026-02-26-1545-p67uuk","company_id":"7561","company":"光晟生技","market":"興櫃","industry":"生技醫療","date":"2026-02-26","time":"15:45:53","subject":"公告本公司內部稽核主管異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：光晟生技（7561），2026-02-26 15:45，「公告本公司內部稽核主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6814-2026-02-26-1542-1pzjlpi","company_id":"6814","company":"路迦生醫","market":"興櫃","industry":"生技醫療","date":"2026-02-26","time":"15:42:39","subject":"公告本公司預估未來三個月現金收支情形及銀行可使用融資額度情形","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：路迦生醫（6814），2026-02-26 15:42，「公告本公司預估未來三個月現金收支情形及銀行可使用融資額度情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4138-2026-02-26-1537-avkbzq","company_id":"4138","company":"曜亞","market":"上櫃","industry":"生技醫療","date":"2026-02-26","time":"15:37:39","subject":"代重要子公司曜胜生技股份有限公司公告董事會決議召開115年股東常會","clause":"第17款","fact_date":"2026-02-26","cite_as":"公開資訊觀測站重大訊息：曜亞（4138），2026-02-26 15:37，「代重要子公司曜胜生技股份有限公司公告董事會決議召開115年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4138-2026-02-26-1536-1abjrto","company_id":"4138","company":"曜亞","market":"上櫃","industry":"生技醫療","date":"2026-02-26","time":"15:36:25","subject":"代重要子公司曜胜生技股份有限公司公告董事會決議通過114年度盈餘分配案","clause":"第14款","fact_date":"2026-02-26","cite_as":"公開資訊觀測站重大訊息：曜亞（4138），2026-02-26 15:36，「代重要子公司曜胜生技股份有限公司公告董事會決議通過114年度盈餘分配案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1731-2026-02-26-1535-11r8ft9","company_id":"1731","company":"美吾華","market":"上市","industry":"生技醫療","date":"2026-02-26","time":"15:35:45","subject":"本公司董事會決議召開民國115年股東常會","clause":"第17款","fact_date":"2026-02-26","cite_as":"公開資訊觀測站重大訊息：美吾華（1731），2026-02-26 15:35，「本公司董事會決議召開民國115年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4138-2026-02-26-1535-1qd3c7","company_id":"4138","company":"曜亞","market":"上櫃","industry":"生技醫療","date":"2026-02-26","time":"15:35:37","subject":"公告114年度財務報告董事會預計召開日期為115年03月06日","clause":"第31款","fact_date":"2026-02-26","cite_as":"公開資訊觀測站重大訊息：曜亞（4138），2026-02-26 15:35，「公告114年度財務報告董事會預計召開日期為115年03月06日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4102-2026-02-26-1530-164krb2","company_id":"4102","company":"永日","market":"上櫃","industry":"生技醫療","date":"2026-02-26","time":"15:30:10","subject":"代重要子公司台灣味群工業股份有限公司公告本公司董事會決議召開115年股東會相關事宜","clause":"第17款","fact_date":"2026-02-26","cite_as":"公開資訊觀測站重大訊息：永日（4102），2026-02-26 15:30，「代重要子公司台灣味群工業股份有限公司公告本公司董事會決議召開115年股東會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4139-2026-02-26-1527-1wlqw5m","company_id":"4139","company":"馬光-KY","market":"上櫃","industry":"生技醫療","date":"2026-02-26","time":"15:27:08","subject":"公告本公司115年1月份自結合併財務報告之負債比率、流動比率及速動比率","clause":"第53款","fact_date":"2026-02-26","cite_as":"公開資訊觀測站重大訊息：馬光-KY（4139），2026-02-26 15:27，「公告本公司115年1月份自結合併財務報告之負債比率、流動比率及速動比率」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1731-2026-02-26-1526-1jbxa8o","company_id":"1731","company":"美吾華","market":"上市","industry":"生技醫療","date":"2026-02-26","time":"15:26:13","subject":"本公司董事會決議配發現金股息每股1.22元","clause":"第14款","fact_date":"2026-02-26","cite_as":"公開資訊觀測站重大訊息：美吾華（1731），2026-02-26 15:26，「本公司董事會決議配發現金股息每股1.22元」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7799-2026-02-26-1525-ryl56g","company_id":"7799","company":"禾榮科","market":"上市","industry":"生技醫療","date":"2026-02-26","time":"15:25:17","subject":"本公司受邀參加元大證券舉辦之2026年第一季投資論壇","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：禾榮科（7799），2026-02-26 15:25，「本公司受邀參加元大證券舉辦之2026年第一季投資論壇」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6767-2026-02-26-1517-1ehvz4m","company_id":"6767","company":"台微醫","market":"上櫃","industry":"生技醫療","date":"2026-02-26","time":"15:17:13","subject":"公告本公司董事會決議不分配股利","clause":"第14款","fact_date":"2026-02-26","cite_as":"公開資訊觀測站重大訊息：台微醫（6767），2026-02-26 15:17，「公告本公司董事會決議不分配股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4102-2026-02-26-1514-f7zdi0","company_id":"4102","company":"永日","market":"上櫃","industry":"生技醫療","date":"2026-02-26","time":"15:14:21","subject":"公告本公司114年度財務報告董事會召開日期","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：永日（4102），2026-02-26 15:14，「公告本公司114年度財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6767-2026-02-26-1509-1s5ilpi","company_id":"6767","company":"台微醫","market":"上櫃","industry":"生技醫療","date":"2026-02-26","time":"15:09:41","subject":"公告本公司因會計師事務所內部調整更換會計師","clause":"第7款","fact_date":"2026-02-26","cite_as":"公開資訊觀測站重大訊息：台微醫（6767），2026-02-26 15:09，「公告本公司因會計師事務所內部調整更換會計師」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6767-2026-02-26-1508-1dd9qx8","company_id":"6767","company":"台微醫","market":"上櫃","industry":"生技醫療","date":"2026-02-26","time":"15:08:14","subject":"公告本公司董事會決議召開115年股東常會事宜","clause":"第17款","fact_date":"2026-02-26","cite_as":"公開資訊觀測站重大訊息：台微醫（6767），2026-02-26 15:08，「公告本公司董事會決議召開115年股東常會事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6767-2026-02-26-1507-2isvc","company_id":"6767","company":"台微醫","market":"上櫃","industry":"生技醫療","date":"2026-02-26","time":"15:07:42","subject":"公告本公司董事會通過解除經理人競業之限制","clause":"第21款","fact_date":"2026-02-26","cite_as":"公開資訊觀測站重大訊息：台微醫（6767），2026-02-26 15:07，「公告本公司董事會通過解除經理人競業之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6767-2026-02-26-1507-fue3vq","company_id":"6767","company":"台微醫","market":"上櫃","industry":"生技醫療","date":"2026-02-26","time":"15:07:15","subject":"董事會通過114年度合併財務報告","clause":"第31款","fact_date":"2026-02-26","cite_as":"公開資訊觀測站重大訊息：台微醫（6767），2026-02-26 15:07，「董事會通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6767-2026-02-26-1506-isqttc","company_id":"6767","company":"台微醫","market":"上櫃","industry":"生技醫療","date":"2026-02-26","time":"15:06:39","subject":"公告本公司董事會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台微醫（6767），2026-02-26 15:06，「公告本公司董事會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2026-02-26-1433-1fuu13h","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2026-02-26","time":"14:33:49","subject":"本公司114年度財務報告提報董事會預計召開日期為115年3月9日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2026-02-26 14:33，「本公司114年度財務報告提報董事會預計召開日期為115年3月9日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6919-2026-02-26-1347-1928hv5","company_id":"6919","company":"康霈*","market":"上市","industry":"生技醫療","date":"2026-02-26","time":"13:47:38","subject":"本公司受邀參加由元大證券舉辦之「2026元大證券第一季投資論壇」","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：康霈*（6919），2026-02-26 13:47，「本公司受邀參加由元大證券舉辦之「2026元大證券第一季投資論壇」」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1731-2026-02-26-1346-5j9yh6","company_id":"1731","company":"美吾華","market":"上市","industry":"生技醫療","date":"2026-02-26","time":"13:46:36","subject":"公告本公司董事會通過114年度合併財務報告","clause":"第31款","fact_date":"2026-02-26","cite_as":"公開資訊觀測站重大訊息：美吾華（1731），2026-02-26 13:46，「公告本公司董事會通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4117-2026-02-26-1324-1szq3ou","company_id":"4117","company":"普生","market":"興櫃","industry":"生技醫療","date":"2026-02-26","time":"13:24:51","subject":"公告本公司115年01月份自結合併財務報告之負債比率、流動比率及速動比率","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：普生（4117），2026-02-26 13:24，「公告本公司115年01月份自結合併財務報告之負債比率、流動比率及速動比率」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4166-2026-02-26-1105-1b2xvos","company_id":"4166","company":"友霖","market":"上櫃","industry":"生技醫療","date":"2026-02-26","time":"11:05:50","subject":"(更正115/02/25序號5重訊主旨) 公告本公司董事會決議114年不分派股利","clause":"第14款","fact_date":"2026-02-25","cite_as":"公開資訊觀測站重大訊息：友霖（4166），2026-02-26 11:05，「(更正115/02/25序號5重訊主旨) 公告本公司董事會決議114年不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8409-2026-02-26-1023-bpt2o7","company_id":"8409","company":"商之器","market":"上櫃","industry":"生技醫療","date":"2026-02-26","time":"10:23:27","subject":"公告本公司114年度財務報告提董事會決議日期","clause":"第31款","fact_date":"2026-02-26","cite_as":"公開資訊觀測站重大訊息：商之器（8409），2026-02-26 10:23，「公告本公司114年度財務報告提董事會決議日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}